New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2013
10:00 EDTQLIK, MVO, HILL, BBT, BCRX, PKI, MAKO, D, AMTG, PRI, GPN, CYSOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: BB&T (BBT) upgraded to Buy from Neutral at Compass Point... CYS Investments (CYS) upgraded to Buy from Neutral at Compass Point... Dominion (D) upgraded to Overweight from Neutral at Atlantic Equities... Dot Hill Systems (HILL) upgraded to Buy from Hold at Needham... Global Payments (GPN) upgraded to Buy from Neutral at Nomura... MAKO Surgical (MAKO) upgraded to Buy from Neutral at Mizuho... MV Oil Trust (MVO) upgraded to Market Perform from Underperform at Raymond James... Primerica (PRI) upgraded to Outperform from Market Perform at Raymond James... Qlik Technologies (QLIK) upgraded to Overweight from Equal Weight at Evercore... PerkinElmer (PKI) upgraded to Strong Buy from Buy at ISI Group... Apollo Residential Mortgage (AMTG) upgraded to Overweight from Neutral at JPMorgan... BioCryst (BCRX) upgraded to Buy from Hold at MLV Equity.
News For BBT;CYS;D;HILL;GPN;MAKO;MVO;PRI;PKI;QLIK;AMTG;BCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2015
14:05 EDTBCRXPatient at UC Davis Medical center tests negative for Ebola, WSJ reports
Subscribe for More Information
07:52 EDTCYSCYS Investments coverage assumed with a Neutral at Nomura
Target $8.75.
January 29, 2015
16:22 EDTPKIPerkinElmer sees FY15 EPS $2.58-$2.64, consensus $2.64
Subscribe for More Information
16:22 EDTPKIPerkinElmer reports Q4 EPS 85c, consensus 78c
Subscribe for More Information
15:37 EDTPKINotable companies reporting after market close
Subscribe for More Information
13:51 EDTBCRXPotential Ebola patient being treated at UC Davis Medical Center, KCRA says
Subscribe for More Information
January 28, 2015
08:45 EDTPRIPrimerica fundamentals have improved, says SunTrust
Subscribe for More Information
January 26, 2015
09:56 EDTBCRXBioCryst management to meet with JPMorgan
Meetings to be held in Boston on January 29-30 hosted by JPMorgan.
09:19 EDTBCRXOn The Fly: Pre-market Movers
Subscribe for More Information
06:59 EDTBCRXBioCryst grants fast track designation for BCX4161
BioCryst announced that the FDA has granted Fast Track designation for BCX4161, a novel, orally administered, selective inhibitor of plasma kallikrein in advanced clinical development for the treatment of hereditary angioedema. BioCryst is enrolling HAE patients in the OPuS-2 trial of BCX4161; a double-blind, randomized, placebo controlled trial conducted in the U.S. and certain EU countries, with the goal of demonstrating the efficacy and safety of BCX4161 treatment for 12 weeks in approximately 100 patients with HAE. BioCryst expects to report results from OPuS-2 by the end of 2015.
January 25, 2015
13:57 EDTBCRXUK nurse make full recovery from Ebola, WSJ says
Subscribe for More Information
January 23, 2015
10:02 EDTQLIKOn the Fly: Analyst Initiation Summary
Subscribe for More Information
January 22, 2015
16:28 EDTQLIKQlik Technologies initiated with an Outperform at Cowen
Target $37.
05:50 EDTBBTBB&T reports Q4 Basel III common equity Tier 1 capital ratio 10.3%
Reports Q4 Tier 1 capital ratio 12.4%.
05:48 EDTBBTBB&T reports Q4 EPS 76c, consensus 73c
Subscribe for More Information
January 21, 2015
15:27 EDTBBTNotable companies reporting before tomorrow's open
Subscribe for More Information
13:51 EDTBBTBB&T February volatility increases into Q4 and outlook
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use